AES ACCELERATED ENROLLMENT SOLUTIONS

Serial Number 90456286
Registration 6567035
700

Registration Progress

Application Filed
Jan 8, 2021
Under Examination
Approved for Publication
Sep 7, 2021
Published for Opposition
Sep 7, 2021
Registered
Nov 23, 2021

Trademark Image

AES ACCELERATED ENROLLMENT SOLUTIONS

Basic Information

Serial Number
90456286
Registration Number
6567035
Filing Date
January 8, 2021
Registration Date
November 23, 2021
Published for Opposition
September 7, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 23, 2021
Registration
Registered
Classes
035 042

Rights Holder

Synexus Clinical Research US, Inc.

03
Address
2005 S Easton Road 
Suite 304
Doylestown, PA 18901

Ownership History

Synexus Clinical Research US, Inc.

Original Applicant
03
Tempe, AZ

Synexus Clinical Research US, Inc.

Owner at Publication
03
Tempe, AZ

Synexus Clinical Research US, Inc.

Original Registrant
03
Doylestown, PA

Legal Representation

Attorney
Kenya L. Williams

USPTO Deadlines

Next Deadline
866 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-11-23)
Due Date
November 23, 2027
Grace Period Ends
May 23, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description
Aug 18, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 23, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 23, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 23, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 23, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 23, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 23, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 16, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 16, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 16, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 7, 2021 PUBO A PUBLISHED FOR OPPOSITION
Sep 7, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 18, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Aug 2, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED
Aug 2, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 2, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Aug 2, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2021 DOCK D ASSIGNED TO EXAMINER
Apr 9, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 8, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 13, 2021 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jan 12, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Business management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes
First Use Anywhere: May 1, 2019
First Use in Commerce: May 1, 2019
Class 042
Clinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials
First Use Anywhere: May 1, 2019
First Use in Commerce: May 1, 2019

Additional Information

Design Mark
The mark consists of a vertical line with the letters "AES" in a stylized font to the left of line and the vertically stacked words "ACCELERATED ENROLLMENT SOLUTIONS" in stylized font to the right of the line.

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ACCELERATED ENROLLMENT SOLUTIONS"